IMPAX LABORATORIES INC's ticker is IPXL and the CUSIP is 45256B101. A total of 180 filers reported holding IMPAX LABORATORIES INC in Q1 2017. The put-call ratio across all filers is 0.50 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2016 | $4,944,000 | -32.2% | 373,148 | +21.4% | 0.01% | -33.3% |
| Q3 2016 | $7,287,000 | -16.8% | 307,477 | +1.2% | 0.01% | -18.2% |
| Q2 2016 | $8,755,000 | -1.7% | 303,791 | +9.2% | 0.01% | -8.3% |
| Q1 2016 | $8,905,000 | -23.0% | 278,093 | +2.9% | 0.01% | -20.0% |
| Q4 2015 | $11,559,000 | +22.0% | 270,323 | +0.5% | 0.02% | +15.4% |
| Q3 2015 | $9,472,000 | -24.5% | 269,010 | -1.5% | 0.01% | -18.8% |
| Q2 2015 | $12,543,000 | +6.1% | 273,155 | +8.3% | 0.02% | +6.7% |
| Q1 2015 | $11,821,000 | +49.6% | 252,201 | +1.1% | 0.02% | +50.0% |
| Q4 2014 | $7,904,000 | +32.6% | 249,485 | -0.8% | 0.01% | +25.0% |
| Q3 2014 | $5,961,000 | -20.3% | 251,424 | +0.8% | 0.01% | -20.0% |
| Q2 2014 | $7,479,000 | +5.2% | 249,371 | -7.4% | 0.01% | 0.0% |
| Q1 2014 | $7,112,000 | +6.3% | 269,191 | +1.1% | 0.01% | 0.0% |
| Q4 2013 | $6,693,000 | +20.4% | 266,234 | -2.0% | 0.01% | +11.1% |
| Q3 2013 | $5,559,000 | +3.3% | 271,563 | +0.6% | 0.01% | -10.0% |
| Q2 2013 | $5,381,000 | – | 269,881 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Krensavage Asset Management, LLC | 423,161 | $13,406,000 | 7.47% |
| Aravt Global | 2,300,000 | $72,864,000 | 5.43% |
| Slate Path Capital LP | 2,330,000 | $73,814,000 | 5.16% |
| Orbimed Advisors | 6,678,000 | $211,559,000 | 2.02% |
| Iguana Healthcare Management, LLC | 100,000 | $3,168,000 | 1.53% |
| Iguana Healthcare Management, LLC | 100,000 | $3,168,000 | 1.53% |
| Penn Capital Management Company, LLC | 709,045 | $22,463,000 | 0.94% |
| HUSSMAN STRATEGIC ADVISORS, INC. | 250,000 | $7,920,000 | 0.79% |
| NEW AMSTERDAM PARTNERS LLC/NY | 276,169 | $8,749,000 | 0.76% |
| Matarin Capital Management, LLC | 52,932 | $1,676,886,000 | 0.74% |